The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin-Reference-Cited by-同舟云学术

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin

Published:2015-11-06 Issue:1 Volume:118 Page:44-52
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Gontero Paolo¹,Sylvester Richard²,Pisano Francesca¹,Joniau Steven³,Oderda Marco¹,Serretta Vincenzo⁴,Larré Stéphane⁵,Di Stasi Savino⁶,Van Rhijn Bas⁷,Witjes Alfred J.⁸,Grotenhuis Anne J.⁸,Colombo Renzo⁹,Briganti Alberto⁹,Babjuk Marek¹⁰,Soukup Viktor¹⁰,Malmström Per-Uno¹¹,Irani Jacques¹²,Malats Nuria¹³,Baniel Jack¹⁴,Mano Roy¹⁴,Cai Tommaso¹⁵,Cha Eugene K.¹⁶,Ardelt Peter¹⁷,Vakarakis John¹⁸,Bartoletti Riccardo¹⁹,Dalbagni Guido²⁰,Shariat Shahrokh F.¹⁶,Xylinas Evanguelos¹⁶,Karnes Robert J.²¹,Palou Joan²²

Affiliation:

1. Urology Clinic; Città della Salute e della Scienza di Torino; University of Studies of Turin; Turin Italy

2. Formerly Department of Biostatistics; EORTC Headquarters; Brussels Belgium

3. Oncologic and Reconstructive Urology; Department of Urology; University Hospitals Leuven; Leuven Belgium

4. Department of Surgical, Oncological and Stomatological Sciences; University of Palermo; Palermo Italy

5. Department of Surgical Science; John Radcliffe Hospital; University of Oxford; Oxford UK

6. Policlinico Tor Vergata-University of Rome; Rome Italy

7. Department of Urology; Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands

8. Department of Urology; Radboud University Nijmegen Medical Centre; Nijmegen The Netherlands

9. Dipartimento di Urologia; Università Vita-Salute. Ospedale S. Raffaele; Milan Italy

10. Department of Urology; Motol Hospital; University of Praha; Praha Czech Republic

11. Department of Urology; Academic Hospital; Uppsala University; Uppsala Sweden

12. Department of Urology; Centre Hospitalier Universitaire La Milétrie; University of Poitiers; Poitiers France

13. Genetic and Molecular Epidemiology Group; Spanish National Cancer Research Centre (CNIO); Madrid Spain

14. Department of Urology; Rabin Medical Centre; Tel Aviv Israel

15. Department of Urology; Santa Chiara Hospital; Trento Italy

16. Department of Urology; Weill Medical College of Cornell University in New York City; New York NY USA

17. Facharzt fur Urologie; Abteilung fur Urologie. Chirurgische Universitats klinik; Freiburg Germany

18. Department of Urology; Sismanoglio Hospital; University of Athens; Athens Greece

19. Department of Experimental and Clinical Medicine; University of Florence; Florence Italy

20. Department of Urology; Memorial Sloan Kettering Cancer Center; New York NY USA

21. Department of Urology; Mayo Clinic; Rochester MN USA

22. Department of Urology; Fundacio Puigvert; University of Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13354/fullpdf

Reference18 articles.

1. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

2. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

3. A re-staging transurethral resection predicts early progression of superficial bladder cancer;Herr;BJU Int,2006

4. Role of re-resection in non-muscle-invasive bladder cancer;Herr;ScientificWorldJournal,2011

5. The value of a second transurethral resection in evaluating patients with bladder tumors;Herr;J Urol,1999

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France;The French Journal of Urology;2024-09

2. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer;World Journal of Urology;2024-08-12

3. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

4. Association of energy source with outcomes in en bloc TURB. Secondary analysis of a randomized trial;2024-07-18

5. Comparative efficacy of Bacillus Calmette–Guérin instillation and radical cystectomy treatments for high-risk non-muscle-invasive urothelial cancer classified as high-grade T1 in initial and repeat transurethral resection of bladder tumor;Frontiers in Oncology;2024-06-18